Molly Went

515 total citations
7 papers, 63 citations indexed

About

Molly Went is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Molly Went has authored 7 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Molly Went's work include Multiple Myeloma Research and Treatments (3 papers), Genetic Associations and Epidemiology (2 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers). Molly Went is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Genetic Associations and Epidemiology (2 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers). Molly Went collaborates with scholars based in United Kingdom, United States and Germany. Molly Went's co-authors include Richard S. Houlston, Markus Hansson, Björn Nilsson, Kari Hemminki, Maroulio Pertesi, Philip Law, Martin Kaiser, Hartmut Goldschmidt, Pieter Sonneveld and Niels Weinhold and has published in prestigious journals such as Nature Communications, Scientific Reports and British Journal of Cancer.

In The Last Decade

Molly Went

5 papers receiving 63 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly Went United Kingdom 4 29 27 16 12 11 7 63
Katayoon Kasaian Canada 2 29 1.0× 15 0.6× 25 1.6× 5 0.4× 10 0.9× 2 70
Wallace Bourgeois United States 5 65 2.2× 38 1.4× 24 1.5× 7 0.6× 7 0.6× 15 137
Leo Ruhnke Germany 5 27 0.9× 29 1.1× 26 1.6× 10 0.8× 6 0.5× 13 79
Charlotte Thompson United Kingdom 5 14 0.5× 12 0.4× 18 1.1× 9 0.8× 3 0.3× 9 75
Jonas Waizenegger Germany 3 23 0.8× 15 0.6× 15 0.9× 3 0.3× 4 0.4× 4 74
Anne Thorwarth Germany 4 35 1.2× 11 0.4× 7 0.4× 16 1.3× 12 1.1× 15 70
Joshua S. Weinstock United States 4 29 1.0× 54 2.0× 7 0.4× 18 1.5× 4 0.4× 5 105
Seonggon Kim South Korea 5 39 1.3× 10 0.4× 9 0.6× 3 0.3× 5 0.5× 8 65
А. В. Попа Russia 4 12 0.4× 8 0.3× 18 1.1× 11 0.9× 9 0.8× 19 54
Xiaoshui Zhou China 4 27 0.9× 15 0.6× 16 1.0× 3 0.3× 3 0.3× 4 89

Countries citing papers authored by Molly Went

Since Specialization
Citations

This map shows the geographic impact of Molly Went's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Went with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Went more than expected).

Fields of papers citing papers by Molly Went

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Went. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Went. The network helps show where Molly Went may publish in the future.

Co-authorship network of co-authors of Molly Went

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Went. A scholar is included among the top collaborators of Molly Went based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Went. Molly Went is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Went, Molly, Philip Law, Ines Gockel, et al.. (2025). Mendelian randomisation analysis to discover plasma metabolites mediating the effect of obesity on cancer risk. British Journal of Cancer. 133(9). 1344–1353.
2.
Went, Molly, C Wood, Amit Sud, et al.. (2025). Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy. Blood Cancer Journal. 15(1). 62–62.
3.
Went, Molly, Amit Sud, Philip Law, et al.. (2024). Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. Nature Communications. 15(1). 2637–2637. 11 indexed citations
4.
Went, Molly, Phuc H. Hoang, Philip Law, Martin Kaiser, & Richard S. Houlston. (2022). Exploiting gene dependency to inform drug development for multiple myeloma. Scientific Reports. 12(1). 12696–12696. 2 indexed citations
5.
Went, Molly, Alex J. Cornish, Philip Law, et al.. (2020). Search for multiple myeloma risk factors using Mendelian randomization. Blood Advances. 4(10). 2172–2179. 26 indexed citations
6.
Pertesi, Maroulio, Molly Went, Markus Hansson, et al.. (2020). Genetic predisposition for multiple myeloma. Leukemia. 34(3). 697–708. 21 indexed citations
7.
Went, Molly, Amit Sud, Ni Li, et al.. (2019). Regions of homozygosity as risk factors for multiple myeloma. Annals of Human Genetics. 83(4). 231–238. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026